Hydroxychloroquine Sulfate
31 NDCs across 15 manufacturers|30 Generic,1 Brand
Hydroxychloroquine Sulfate is used to treat rheumatoid arthritis, systemic lupus erythematosus, malaria, photosensitivity disorders and porphyria cutanea tarda, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Sep 30, 1994. FDA's Orange Book lists 20 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $104 million on Hydroxychloroquine Sulfate across 2.5 million claims for 628,000 beneficiaries.
Hydroxychloroquine Sulfate is available as 31 NDCs from 15 manufacturers (30 generic, 1 brand), with NADAC prices from $0.15 to $9.11 per EA — the most expensive product costs about 61× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
31
30G / 1B
Manufacturers
15
competing in market
Price Spread
$0.15 – $9.11
per EA
7d Activity
avg +0.6% WoW · of 31 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antimalarial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
15 manufacturers producing HYDROXYCHLOROQUINE SULFATE(3 pricing outliers)
Frequently Asked Questions
What is Hydroxychloroquine Sulfate used to treat?
Hydroxychloroquine Sulfate is used to treat rheumatoid arthritis, systemic lupus erythematosus, malaria, photosensitivity disorders and porphyria cutanea tarda, per the National Library of Medicine's MED-RT classification.
When did Hydroxychloroquine Sulfate become available as a generic?
FDA approved the first generic Hydroxychloroquine Sulfate (ANDA) on Sep 30, 1994. The Orange Book currently lists 20 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Hydroxychloroquine Sulfate?
In 2024, Medicare Part D spent $104 million on Hydroxychloroquine Sulfate across 2.5 million claims for 628,000 beneficiaries.
How many Hydroxychloroquine Sulfate products are on the market?
The Hydroxychloroquine Sulfate drug market contains 31 NDCs from 15 manufacturers — 30 generic and 1 brand product.
What is the price range for Hydroxychloroquine Sulfate?
NADAC reference prices for Hydroxychloroquine Sulfate range from $0.1490 to $9.1099 per EA — the most expensive product costs about 61× the cheapest.
Is generic Hydroxychloroquine Sulfate cheaper than brand?
The average generic NADAC for Hydroxychloroquine Sulfate is $0.2083 per EA, versus $9.1099 for brand-labeled products — brand versions average about 44× the generic price.
Which manufacturers make Hydroxychloroquine Sulfate?
15 manufacturers list Hydroxychloroquine Sulfate in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (5), Accord Healthcare Inc. (5), Sun Pharmaceutical Industries Inc. (2), Aurobindo Pharma Limited (2), Zydus Pharmaceuticals (USA) Inc. (2).
How has the price of Hydroxychloroquine Sulfate changed recently?
Over the past 7 days, 50 Hydroxychloroquine Sulfate NDCs rose and 0 fell, with a market-wide average change of +0.6%.